Inventor profile of:

Alex Nivorozhkin

City:

West Roxbury, Massachusetts

Country:

United States

Published Applications:

53

Last publication date:

2026-06-18

Top Assignees for applications by Alex Nivorozhkin

The entities that hold a legal rights for patent applications filed by inventor Nivorozhkin Alex:

Recent patent applications by Nivorozhkin Alex

Alex Nivorozhkin from West Roxbury, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-06-18
US20260167603A1
Chemistry; metallurgy

PHENETHYLAMINE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE

#2 | 2026-04-30
US20260114492A1
Human necessities

ORAL DELIVERY PRODUCTS

#3 | 2026-04-23
US20260109663A1
Chemistry; metallurgy

NEURO-ATTENUATING KETAMINE AND NORKETAMINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS

#4 | 2025-11-27
US20250360148A1
Human necessities

SOLID DISPERSIONS OF PSILOCYBIN

#5 | 2025-07-24
US20250236589A1
Chemistry; metallurgy

THERAPEUTIC PHENETHYLAMINE COMPOSITIONS AND METHODS OF USE

#6 | 2025-07-17
US20250230128A1
Chemistry; metallurgy

DEUTERATED TRYPTAMINE DERIVATIVES AND METHODS OF USE

#7 | 2025-07-10
US20250223273A1
Chemistry; metallurgy

METHODS AND RELATED TOOLS FOR CBD CONVERSION TO THC

#8 | 2025-07-03
US20250213527A1
Human necessities

FORMULATIONS OF PSILOCYBIN ANALOGS AND METHODS OF USE

#9 | 2025-06-26
US20250205198A1
Human necessities

METHODS FOR DELIVERY OF PSYCHEDELIC MEDICATIONS BY INHALATION AND SYSTEMS FOR PERFORMING THE METHODS

#10 | 2025-05-15
US20250154101A1
Chemistry; metallurgy

DEUTERATED TRYPTAMINE DERIVATIVES AND METHODS OF USE

#11 | 2025-05-08
US20250145566A1
Chemistry; metallurgy

PHENETHYLAMINE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE

#12 | 2025-03-13
US20250082607A2
Human necessities

METHODS OF TREATING DISORDERS WITH A PSILOCYBIN ANALOG

#13 | 2025-02-13
US20250051279A1
Chemistry; metallurgy

TRYPTAMINE COMPOSITIONS AND METHODS

#14 | 2025-01-09
US20250011282A1
Chemistry; metallurgy

DEUTERATED TRYPTAMINE DERIVATIVES AND METHODS OF USE

#15 | 2024-12-26
US20240425451A1
Chemistry; metallurgy

THERAPEUTIC PHENETHYLAMINE COMPOSITIONS AND METHODS OF USE

#16 | 2024-11-07
US20240366655A1
Human necessities

COMBINATION DRUG THERAPIES

#17 | 2024-09-26
US20240317704A1
Chemistry; metallurgy

PHENETHYLAMINE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE

#18 | 2024-09-05
US20240293367A1
Human necessities

METHODS OF TREATING DISORDERS WITH A PSILOCYBIN ANALOG

#19 | 2024-08-15
US20240270691A1
Chemistry; metallurgy

Deuterated tryptamine derivatives and methods of use

#20 | 2024-08-08
US20240261306A1
Human necessities

FORMULATIONS OF PSILOCYBIN

#21 | 2024-05-30
US20240174607A1
Chemistry; metallurgy

PSILOCYBIN ANALOGS, SALTS, COMPOSITIONS, AND METHODS OF USE

#22 | 2024-02-29
US20240067605A1
Chemistry; metallurgy

Deuterated tryptamine derivatives and methods of use

#23 | 2023-11-09
US20230357147A1
Chemistry; metallurgy

Deuterated tryptamine derivatives and methods of use

#24 | 2023-11-09
US20230355583A1
Human necessities

METHODS FOR DELIVERY OF PSYCHEDELIC MEDICATIONS BY INHALATION AND SYSTEMS FOR PERFORMING THE METHODS

#25 | 2023-10-05
US20230312464A1
Chemistry; metallurgy

Therapeutic phenethylamine compositions and methods of use

#26 | 2023-07-13
US20230219889A1
Chemistry; metallurgy

Deuterated tryptamine derivatives and methods of use

#27 | 2023-06-29
US20230202979A1
Chemistry; metallurgy

Deuterated tryptamine derivatives and methods of use

#28 | 2023-06-22
US20230192593A1
Chemistry; metallurgy

NEURO-ATTENUATING KETAMINE AND NORKETAMINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS

#29 | 2023-03-02
US20230066286A1
Chemistry; metallurgy

Deuterated tryptamine derivatives and methods of use

#30 | 2022-12-22
US20220402863A1
Chemistry; metallurgy

Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods

#31 | 2022-04-21
US20220119346A1
Chemistry; metallurgy

Deuterated tryptamine derivatives and methods of use

#32 | 2022-04-07
US20220106258A1
Chemistry; metallurgy

Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods

#33 | 2021-11-25
US20210363125A1
Chemistry; metallurgy

Methods and related tools for CBD conversion to THC

#34 | 2021-11-25
US20210363104A1
Chemistry; metallurgy

Deuterated tryptamine derivatives and methods of use

#35 | 2020-08-20
US20200261370A1
Human necessities

Single-layer oral dose of neuro-attenuating ketamine

#36 | 2020-07-16
US20200223814A1
Chemistry; metallurgy

Methods and related tools for CBD conversion to THC

#37 | 2019-08-29
US20190263749A1
Chemistry; metallurgy

Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods

#38 | 2019-08-15
US20190250137A1
Physics

SYSTEM AND METHOD FOR DETECTION OF A CONTAMINATED BEVERAGE

#39 | 2018-06-07
US20180153813A1
Human necessities

Single layer oral dose of neuro-attenuating ketamine

#40 | 2017-12-14
US20170355663A1
Chemistry; metallurgy

Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods

#41 | 2017-06-08
US20170160253A1
Physics

System and method for detection of a contaminated beverage

#42 | 2016-07-14
US20160199304A1
Human necessities

Single-layer oral dose of neuro-attenuating ketamine

#43 | 2016-05-26
US20160146773A1
Physics

System and method for detection of a contaminated beverage

#44 | 2015-04-16
US20150104861A1
Physics

System and method for detection of a contaminated beverage

#45 | 2014-11-06
US20140329764A1
Human necessities

Methods of use of HSP70 for increased performance or treatment of HSP70 related disorders

#46 | 2013-06-20
US20130156694A1
Chemistry; metallurgy

HSP70 fusion protein conjugates and uses thereof

#47 | 2013-04-25
US20130101573A1
Human necessities

Degradation resistant HSP70 formulations and uses thereof

#48 | 2013-04-11
US20130090294A1
Human necessities

NOVEL METHODS OF USE OF HSP70 FOR INCREASED PERFORMANCE OR TREATMENT OF HSP70 RELATED DISORDERS

#49 | 2010-02-11
US20100035886A1
Human necessities

PARENTERAL FORMULATIONS OF DOPAMINE AGONISTS

#50 | 2006-08-08
US10620619
-

Aryltetrazole compounds, and compositions thereof

#51 | 2006-07-18
US10197609
-

5-Aryltetrazole compounds, compositions thereof, and uses therefor

#52 | 2005-07-21
US20050159467A1
Chemistry; metallurgy

5-Aryltetrazole compounds and uses thereof

#53 | 2005-07-21
US20050159418A1
Chemistry; metallurgy

5-Aryltetrazoles compounds and compositions thereof

InventorID:

187748 ⎘